CML and apoptosis: The Ceramide pathway

Hematology and Cell Therapy

Volumn 40, Issue 5, 1998, Pages 233-236

  Maguer Satta, V ^a  

^a CENTRE LÉON BÉRARD   (France)

Author keywords

Apoptosis; Ceramide; CML; Signaling pathways

Indexed keywords

BCR ABL PROTEIN; CERAMIDE; PROTEIN BCL 2;

APOPTOSIS; CELL PROLIFERATION; CELL TRANSFORMATION; CHRONIC MYELOID LEUKEMIA; CONFERENCE PAPER; ENZYME ACTIVITY; HEMATOPOIETIC STEM CELL; HUMAN; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; APOPTOSIS; CELL DIVISION; CELL SURVIVAL; CELL TRANSFORMATION, NEOPLASTIC; CERAMIDES; FUSION PROTEINS, BCR-ABL; GROWTH SUBSTANCES; HUMANS; LEUKEMIA, MYELOID, CHRONIC; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-BCL-2; SIGNAL TRANSDUCTION;

EID: 0031742058     PISSN: 12693286     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (29)

1. Albrecht T, Schwab R, Peschel C, Huber C, Aulitzky WE (1996) Primary proliferating immature myeloid cells from CML patients are not resistant to induction of apoptosis by DNA damage and growth factor withdrawal. Br J Haematol 95: 501-507
2. Amarante-Mendes GP, McGahon AJ, Nishioka WK, Afar DE, Witte ON, Green DR (1998) Bcl2-independent Bcr-Abl -mediated resistance to apoptosis: protection is correlated with up regulation of BclXL, Oncogene 16: 1383-1390
3. Amos TAS, Lewis JL, Grand FH, Gooding RP, Goldman JM, Gordon MY (1995) Apoptosis in chronic myeloid leukaemia: responses by progenitor cells to growth factor deprivation, X-radiation and glucocorticoids. Br J Haematol 91: 387-393
4. Andoniou CE, Thien CBF, Langdon WY (1994) Tumor induction by activated abl involves tyrosine phosphorylation of the product of the cbl oncogene. Embo 13: 4515-4523
5. Bedi A, Barber J, Bedi G, et al (1995) BCR-ABL-mediated inhibition of apoptosis with delay of G2/M transition after DNA damage: a mechanism of resistance to multiple anticancer agents. Blood 86: 1148-1158
6. Bedi A, Zehnauer B, Barber J, Sharkis S, Jones R. (1994). Inhibition of apoptosis by BCR-ABL in chronic myeloid leukemia. Blood 83: 2038-2044
7. Carroll M, Ohno-Jones S, Tamura S, et al (1997) CGP57148, a tyrosine kinase inhibitor, inhibits the growth of cells expressing, BCR-ABL,TEL(ABL and TEL-PDGFR fusion proteins. Blood 90: 4947-49-52
8. Damen JE, Liu L, Rosten P, et al (1996) The 145-kDa protein induced to associate with Shc by multiple cytokines is an inositol tetraphosphate and phosphatidylinositol 3,4,5-triphosphate 5-phosphatase. Proc Natl Acad Sci USA 93: 1689-1693
9. Dubrez L, Eymin B, Sordet O, et al (1998) Bcr-Abl delays apoptosis upstream of procaspase-3 activation. Blood 91: 2415-2422
10. Franke TF, Kaplan DR, Cantley LC (1997) PI3K: Downstream AKTion blocks apoptosis. Cell 88: 435-437
11. Gulbins E, Bissonnette R, Mahboubi A, et al (1995) Fas-induced apoptosis is mediated via a ceramided-initiated Ras signaling pathway. Immunity 2: 341-351
12. Handa H, Hegde UP, Kotelnikov VM, et al (1997) Bcl2 and c-myc expression, cell cycle kinetics and apoptosis during the progression of chronic myelogenous leukemia from diagnosis to blastic phase. Leukemia Res 21: 479-489
13. Hannun YA, Obeid LM (1995) Ceramide: an intracellular signal for apoptosis. Trends Biochem Sci 20: 73-77
14. Hsu S-C, Wu C-C, Luh T-Y, et al (1998) Apoptotic signal of Fas is not mediated by Ceramide. Blood 91: 2658-2663
15. Kolesnick R, Golde DW (1994) The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling. Cell 77: 325-328
16. Liu L, Damen JE, Cutler RL, Krystal G (1997) The SH2 domain of SHIP is essential for SHIP'S tyrosine phosphorylation, its association with SHC and its induction of apoptosis. J Biol Chem 272: 8983-8988
17. Maguer-Satta V, Burl S, Liu L, et al (1998) BCR-ABL accelerates C2-ceramide-induced apoptosis. Oncogene 16: 237-248
18. Maguer-Satta V, Lagarde V, Belloc F, et al (1998) Ceramide-induced apoptosis in chronic myeloid leukemic cells does not involved Bcr-Abl and PI3 kinases activity. Submitted
19. Maguer-Satta V, Petzer AL, Eaves AC, Eaves CJ (1996) BCR-ABL expression in different subpopulations of functionnally characterized Ph+ CD34+ cells from patients with Chronic Myeloid Leukemia. 88: 1796-1804
20. Mancini M, Nicholson DW, Roy S, et al (1998) The caspase-3 precursor has a cytosolic and mitochondrial distribution: implications for apoptotic signaling. J Cell Biol 140: 1485-1495
21. Martin SJ, Reutelingsperger CPM, McGahon AJ, et al (1995) Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: Inhibition by overexpression of Bcl2 and Abl. J Exp Med 182: 1545-1556
22. Nagata S (1997) Apoptosis by death factor. Cell 88: 355-365
23. Obeid LM, Linardic CM, Karolak LA, Hannun YA (1993) Programmed cell death induced by Ceramide. Science 259: 1769-1771
24. Puil L, Liu J, Gish G, et al (1994) Bcr-Abl oncoproteins bind directly to activators of the Ras signalling pathway. Embo 13: 764-773
25. Rameh LE, Chen CS, Cantley LC (1995) Phosphatidylinositol (3,4,5)P3 interacts with SH2 domains and modulates PI3-kinase association with tyrosine-phosphorylated proteins. Cell 83: 821-830
26. Sanchez-Garcia I, Grutz G (1995) Tumorigenicity activity of the BCR-ABL oncogenes is mediated by BCL2. Proc Natl Acad Sci USA 92: 5287-5291
27. Selleri C, Sato T, Del Vecchio L, et al (1997) Involvement of Fasmediated apoptosis in the inhibitory effects of the interferon-α in chronic myelogenous leukemia. Blood 89: 957-964
28. Skorski T, Kananaraj P, Nieborowska-Skorska M, et al (1995) Phosphatidylinositol-3 kinase activity is regulated by BCR/ABL and is required for the growth of Philadelphia chromosome positive cells. Blood 86: 726-736
29. Tauchi T, Feng G-S, Shen R, et al (1994) SH2-containing phosphotyrosine phosphatase Syp is a target of p210 bcr-abl tyrosine kinase. J Biol Chem 269: 15381-15387